🔎 Trials Near Me

Beranda › Fibrosis Paru Idiopatik › Alabama

Uji klinis Fibrosis Paru Idiopatik di Alabama

9 studi untuk Fibrosis Paru Idiopatik mencari peserta di lokasi di Alabama.

Kota di Alabama

Teks studi resmi (Bahasa Inggris)

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

  • University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06951217

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

  • Research Site, Birmingham
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07652658

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • UAB, Psychiatry and Behavioral Neurology, Birmingham
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • UAB Lung Health Center, Birmingham
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06968845

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

  • The University of Alabama at Birmingham /ID# 277613, Birmingham
  • Sec Clinical Research - East - Dothan - Graceland /ID# 278328, Dothan
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07230288

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

  • The University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 1
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT04362644

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Alabama - Birmingham, Birmingham
Menerima pesertaStudi observasional
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT01915511

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

  • WISPer Site in Birmingham, AL, Birmingham
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06967805

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 12 Nov 2025 · NCT05975983

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.